The Role of Blood Pressure Regulation in Uremia

  • Donald J. Sherrard


The risks of high blood pressure and the benefits of its control are well established in the nonuremic population.(1,2) Less well-controlled, older studies strongly support the benefits of blood pressure reduction in patients with moderate renal insufficiency.(3) There is little reason to doubt that treatment of hypertension is an important facet of the care of patients with end-stage renal disease. Indeed, attempts to prove this contention with studies that included a control group of untreated hypertensives would not be ethically defensible.


Maintenance Hemodialysis Dialysis Population Blood Pressure Center Untreated Hypertensive Veteran Administration Cooperative Study 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Veterans Administration Cooperative Study on Antihypertensive agents: Effects of treatment on morbidity in hypertension: Results in patients with diastolic blood pressures averaging 115 through 129 mm Hg. JAMA 202:116–122, 1967.CrossRefGoogle Scholar
  2. 2.
    Veterans Administration Cooperative Study on Antihypertensive Agents: Effects of treatment on morbidity in hypertension: II—Results in patients with diastolic blood pressure averaging 90 through 114 mm Hg. JAMA 213:1143–1152, 1970.CrossRefGoogle Scholar
  3. 3.
    Harrington M, Kincaid-Smith P, McMichael J: Results of treatment in malignant hypertension. Br Med J 2:969–980, 1959.CrossRefGoogle Scholar
  4. 4.
    Vertes V, Cangiano JL, Berman LB, Gould A: Hypertension in end-stage renal disease. N Engl J Med 280:978–981, 1969.PubMedCrossRefGoogle Scholar
  5. 5.
    Brunner HP, Wauters J-P, McKintry D, Waeber B, Gustave-Turini A, Gavras H: Inappropriate renin secretion unmasked by Captopril in hypertension of chronic renal failure. Lancet 2:704–707, 1978.PubMedCrossRefGoogle Scholar
  6. 6.
    Lindner A, Douglas SW, Adamson JW: Effects of propranolol in long term hemodialysis patients with renin-dependent hypertension. Ann Intern Med 88:457–462, 1978.PubMedGoogle Scholar
  7. 7.
    Limas CJ, Fries ED: Minoxidil in severe hypertension with renal failure: Effect of its addition to conventional antihypertensive drugs. Am J Cardiol 31:355–361, 1973.PubMedCrossRefGoogle Scholar
  8. 8.
    Goldberg AP, Hagberg JM, Delmeg JA, Haynes ME, Harter HR: Metabolic effects of exercise training in hemodialysis patients. Kidney Int 18:754–761, 1980.PubMedCrossRefGoogle Scholar
  9. 9.
    Page IH: Two cheers for hypertension. JAMA 242:2559–2560, 1979.PubMedCrossRefGoogle Scholar
  10. 10.
    Lindner A, Charra B, Sherrard DJ, Scribner BH: Accelerated atherosclerosis in prolonged maintenance hemodialysis. N Engl J Med 290:697–701, 1974.PubMedCrossRefGoogle Scholar
  11. 11.
    Gurland HJ, Brunner FP, von Dehn H, Härlen H, Parsona FM, Scharer K: Combined report on regular dialysis and transplantation in Europe. Proc Eur Dial Transpl Assoc 10:17–57, 1973.Google Scholar
  12. 12.
    Burke JF, Francos GC, Moore LL, Cho SY, Lasker N: Accelerated atherosclerosis in chronic dialysis patients—another look. Nephron 21:181–187, 1978.PubMedCrossRefGoogle Scholar
  13. 13.
    Rostand SG, Gretes JC, Kirk KA, Rutsky EA, Andreoli TE: Ischemic heart disease in patients with uremia undergoing maintenance hemodialysis. Kidney Int 16:600–611, 1979.PubMedCrossRefGoogle Scholar
  14. 14.
    Haire HM, Sherrard DJ, Scardapane D, Curtis FK, Brunzell JD: Smoking, hypertension and mortality in a maintenance dialysis population. Cardiovasc Med 3:1163–1168, 1978.Google Scholar
  15. 15.
    Haas LB, Brunzell JD, Sherrard DJ: Atherosclerotic risk factors in a chronic dialysis population. Kidney Int 16:888A, 1979.Google Scholar
  16. 16.
    Vincenti F, Amend WJ, Abele J, Feduska NJ, Salvatierra O: The role of hypotension in hemodialysis-associated atherosclerosis. Am J Med 68:363–369, 1980.PubMedCrossRefGoogle Scholar
  17. 17.
    Goodman WG, Haas LB, Sherrard DJ: Left ventricular hypertrophy and dialysis survival. Clin Res 27:61A, 1979.Google Scholar
  18. 18.
    Guttman RD: Renal transplantation. N Engl J Med 301:1038–1048, 1979.CrossRefGoogle Scholar
  19. 19.
    The Advisory Committee to the Renal Transplant Registry: The 12th report of the human renal transplant registry. JAMA 233:787–796, 1975.CrossRefGoogle Scholar

Copyright information

© Plenum Publishing Corporation 1985

Authors and Affiliations

  • Donald J. Sherrard
    • 1
  1. 1.Dialysis UnitVeterans Administration Medical CenterSeattleUSA

Personalised recommendations